Julie Jordan
Fortune : 55 886 $ au 31/05/2026
Fortune : 55 886 $ au 31/05/2026
Julie Jordan is currently Chief Medical Officer at Neurogene, Inc. since 2024.
Former positions include Senior VP, Head-Clinical Development & Operations at Homology Medicines, Inc. from 2022 to 2023, Senior Director-Clinical Development at Cerevel Therapeutics, Inc. from 2019 to 2021, and Executive Director-Clinical Development at Avanir Pharmaceuticals, Inc. in 2019.
Education includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 07/04/2026 | 1 972 ( 0,01 % ) | 55 886 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Corporate Officer/Principal | 01/04/2021 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2019 |
| Q32 BIO INC. | Directeur des opérations | 09/03/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national